 Home > Medical News > Medical Research Articles > BeiGene announced that Baiyueze (R) (Zebutinib) was approved in the EU for the treatment of adult Fahrenheit macroglobulinemia

BeiGene announced that Baiyueze (R) (Zebutinib) was approved in the EU for the treatment of adult Fahrenheit macroglobulinemia

 Last Update: 2022-01-04
 Source: Internet
 Author: User

Tags

use peroxide

flexeril drug test

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Following the recent approvals in the United States, China, Brazil and Canada, Baiyueze ^® was approved in the European Union

Based on this approval Perrier Chak ^{& reg;}for Bi Yibu imatinib 3 Qi ASPEN head-to-head clinical trials

Beijing, China, Basel, Switzerland and Cambridge, Massachusetts, November 24, 2021/PRNewswire/ - BeiGene (Nasdaq: BGNE; Hong Kong Stock Exchange: 06160) announced today that the European Commission ( EC) Approval of Baiyueze ^® (Zebutinib) for the treatment of adult patients with Waldenstrom's macroglobulinemia (WM) who have received at least one treatment in the past, or as a first-line treatment option for WM patients who are not suitable for chemotherapy and immunotherapy

"Although BTK inhibitors have become a relatively mature therapy for WM ^, the approval of Baiyueze ^® still provides an important new treatment option for WM patients, which is expected to improve the treatment outcome of patients

Following the positive opinion of the European Medicines Agency (EMA) Committee on Medicines for Human Use (CHMP) in September, Baiyueze ^® was approved by the European Commission this time based on the results of the ASPEN trial

Dr.

Gerwin Winter, senior vice president of BeiGene and head of European commercialization, said: “We have established a strong team in Europe and are committed to delivering Baiyueze ^® to WM patients in need as soon as possible

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.